Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RXI-109 for the outcome of keloid excision in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• RXI-109 (RXI-109)

Snippet

Sponsor: RXi Pharmaceuticals, Corp. | Conditions: Keloid | Phase 2 | Status: COMPLETED